drugset / Trial / NCT00247078

The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism

NCT00247078 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of an investigational antivenom and the current standard of care (pain management with opioid analgesics) for treating patients with a widow spider bite. The working hypotheses are as follows: 1. the investigational antivenom is more promptly effective at alleviating the pain associated with a widow spider bite than routine management with opioid pain medication 2. the investigational antivenom is as safe a treatment as opioid pain medication in treating patients with a widow spider bite.

Timeline

Start
2005-10
Primary completion
2006-10
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Analatro Protein / enzyme biologic 3 unknown Intravenous